Loading…
Altimmune, Inc. is projected to rise to $3.98 by 2027, a +31% move from its current price of $3.05. ALT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $2.98 | $3.05 | $3.13 | +0.03% |
| Jul 14 | $2.95 | $3.05 | $3.16 | +0.05% |
| Jul 15 | $2.92 | $3.05 | $3.19 | +0.08% |
| Jul 16 | $2.90 | $3.05 | $3.21 | +0.10% |
| Jul 17 | $2.89 | $3.05 | $3.23 | +0.13% |
| Jul 18 | $2.87 | $3.05 | $3.25 | +0.15% |
| Jul 19 | $2.86 | $3.06 | $3.26 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.86 | $3.06 | $3.26 | +0.18% |
| Week 2 | $2.79 | $3.06 | $3.36 | +0.35% |
| Week 3 | $2.73 | $3.07 | $3.44 | +0.53% |
| Week 4 | $2.69 | $3.07 | $3.51 | +0.71% |
| Week 5 | $2.65 | $3.08 | $3.57 | +0.88% |
| Week 6 | $2.62 | $3.08 | $3.62 | +1.06% |
| Week 7 | $2.59 | $3.09 | $3.68 | +1.24% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease.
The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
Altimmune, Inc. (ALT) is a healthcare stock trading at $3.15 per share. The company has a market capitalization of $612.59M and is ranked 2921 in market cap terms.
Current price, market cap, and rank place ALT in the smaller cap tier of the healthcare space, with a focus on its late-stage pipeline and potential for value inflection as pemvidutide progresses through Phase 3 trials.
A major floor 22.5% below — a decisive break under it would weaken the trend.
The nearest floor, 15.1% below — buyers have tended to step in here.
The nearest ceiling, 3.6% above — a clean break opens room to run.
A major ceiling 40.0% above — clearing it would confirm fresh momentum.
Key ALT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.08 | Sell | $3.07 | Sell |
| MA 10 | $3.05 | Buy | $3.04 | Buy |
| MA 20 | $2.90 | Buy | $2.97 | Buy |
| MA 50 | $2.90 | Buy | $3.00 | Buy |
| MA 100 | $3.25 | Sell | $3.27 | Sell |
| MA 200 | $3.84 | Sell | $3.74 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.47 | Neutral |
| Stoch RSI (14) | 42.37 | Neutral |
| CCI (20) | 60.16 | Neutral |
| Williams %R (14) | -32.35 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 4.81 | Buy |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 67.65 | Neutral |
| TRIX (15) | 0.19 | Buy |
| Awesome (5,34) | 0.19 | Buy |
| Ultimate (7,14,28) | 55.34 | Neutral |
| Momentum (10) | 0.18 | Buy |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 3.09 | Sell |
| ADX (14) | 16.70 | Neutral |
| ATR (14) | 0.07 | Info |
The 30-day technical picture is bullish overall.
RSI(14) sits at 60, suggesting neutral-to-bullish momentum. The 50-day moving average (SMA50) is $2.89 and the 200-day moving average (SMA200) is $3.86, providing near-term support and resistance context. The defined support is $2.59 and resistance is $3.15, framing a trading corridor for the next month.
The 30-day price range spans from $2.62 to $3.79, indicating a modest crest above the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.59 | $3.05 | $4.21 | 0% | Neutral | |
| $3.19 | $3.98 | $5.23 | +31% | Bullish | |
| $3.50 | $4.47 | $6.09 | +47% | Bullish | |
| $3.50 | $4.56 | $6.38 | +50% | Bullish | |
| $3.61 | $4.80 | $6.87 | +57% | Bullish | |
| $3.64 | $4.93 | $7.19 | +62% | Bullish | |
| $3.76 | $5.16 | $7.66 | +69% | Bullish | |
| $4.41 | $6.15 | $9.28 | +102% | Bullish | |
| $4.84 | $6.84 | $10.47 | +124% | Bullish | |
| $5.11 | $7.32 | $11.36 | +140% | Bullish | |
| $6.53 | $9.93 | $16.33 | +225% | Bullish | |
| $9.84 | $16.56 | $29.65 | +443% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.59 | $3.05 | $3.61 | +0.00% |
| August 2026 | $2.64 | $3.11 | $3.76 | +2.12% |
| September 2026 | $2.63 | $3.12 | $3.81 | +0.20% |
| October 2026 | $2.59 | $3.09 | $3.80 | -0.99% |
| November 2026 | $2.68 | $3.21 | $3.98 | +3.89% |
| December 2026 | $2.80 | $3.37 | $4.21 | +5.08% |
Click any year to see its month-by-month ALT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Altimmune, Inc.'s 2026 outlook centres on $3.05, within a $2.59 to $4.21 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ALT could reach as high as $5.23, with a base case around $3.98 and support toward $3.19 — roughly +31% from $3.05. Buyers look set to stay in control over this stretch.
Expect ALT to range from $3.50 to $6.09 through 2028. The $4.47 average target implies a +47% move from current prices. That is up +12% on the projected 2027 average. Momentum favours further upside here.
The ALT price prediction for 2029 points to an average of $4.56 (low $3.50, high $6.38) — a potential gain of +50% on today's $3.05. Buyers look set to stay in control over this stretch.
In 2030, ALT is projected to trade between $3.61 and $6.87, averaging $4.80 — a potential gain of +57% from today's $3.05. That is up +5% on the projected 2029 average. Momentum favours further upside here.
Altimmune, Inc.'s 2031 outlook centres on $4.93, within a $3.64 to $7.19 range. That is up +3% on the projected 2030 average. That marks a +62% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, ALT could reach as high as $7.66, with a base case around $5.16 and support toward $3.76 — roughly +69% from $3.05. Momentum favours further upside here.
Expect ALT to range from $4.41 to $9.28 through 2033. The $6.15 average target implies a +102% move from current prices. That is up +19% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The ALT price prediction for 2034 points to an average of $6.84 (low $4.84, high $10.47) — a potential gain of +124% on today's $3.05. Momentum favours further upside here.
In 2035, ALT is projected to trade between $5.11 and $11.36, averaging $7.32 — a potential gain of +140% from today's $3.05. That is up +7% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Altimmune, Inc.'s 2040 outlook centres on $9.93, within a $6.53 to $16.33 range. That is up +36% on the projected 2035 average. That marks a +225% change versus current levels. Momentum favours further upside here.
By 2050, ALT could reach as high as $29.65, with a base case around $16.56 and support toward $9.84 — roughly +443% from $3.05. Buyers look set to stay in control over this stretch.
Investing $1,000 in ALT today (≈ 327.868852 ALT) could be worth
$5,428.73
+$4,428.73 (+443%) by 2050 · US Dollar
Based on the average projected ALT price of $16.56 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALTwould be worth at today's price.
$1,000 invested in ALT on Jul 10, 2025 (≈ 227.272722 ALT) would be worth
$693.18
-$306.82 (-30.7%) today · 0.69× · US Dollar
Based on a ALT entry price of $4.4 vs. today's $3.05.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.16 | $965.19 | -3.5% |
| 1 month ago | $2.61 | $1,168.58 | +16.9% |
| 3 months ago | $3.24 | $941.36 | -5.9% |
| 6 months ago | $4.05 | $753.09 | -24.7% |
| 1 year ago | $4.4 | $693.18 | -30.7% |
| All time (5.0y) ago | $8.6 | $354.65 | -64.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALT forecast.
Our base-case forecast reaches $6.10 around 2033.
Implied market cap at $6.10: $1.19B
The multi-year forecast shows a clear uptrend in average prices with rising investor expectations.
For 2030, the model projects an avg price of $5.01 with a 59.1% ROI and a bullish sentiment. By 2040, the average price rises to $10.58 with a 236% ROI, continuing the bullish trajectory. In 2050, the avg price is forecast at $17.35 with a 450.9% ROI and a bullish sentiment.
Earlier years in the chain show progressive gains, with 2027 avg $4.17 (ROI 32.2%), 2028 avg $4.77 (ROI 51.5%), and 2029 avg $4.80 (ROI 52.4%), supporting a longer-run upside across the forecast horizon. These figures illustrate potential upside despite inherent uncertainty and are not a guarantee of future results.
Tap a question to reveal the answer.
In 2030 the forecast shows an average price of $5.01 with a minimum of $3.70 and a maximum of $7.32, corresponding to a 59.1% ROI and bullish sentiment.
Forecasts point to bullish sentiment from 2027 onward, with the average price rising to $5.01 by 2030 and $17.35 by 2050, and ROI up to 450.9% in 2050. These are estimates, not guarantees.
Yes. The 2027 forecast shows an average price of $4.17, with a minimum of $3.31 and a maximum of $5.56, while 2026 shows an average of $3.15. This indicates the possibility of surpassing $4 in the forecast period.
The current price is $3.15. The market capitalization is $612.59M, and the rank is 2921.
The 30-day picture is bullish with RSI(14) at 60. The SMA50 is $2.89 and the SMA200 is $3.86. Support is $2.59 and resistance is $3.15, with a 30-day range of $2.62 to $3.79.
Altimmune, Inc. Community Discussion
0Share your Altimmune, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.